Tag Archives: Epstein Barr virus

Different responses to EBV in MS and CFS could lead to diagnostic marker

Posted on 05/20/2014 by wames

Abstract Most humans carry a considerable number of persisting viral infections, frequently in a latent state. Chronic infections may intermittently reactivate especially under immune suppression and play an important role as trigger or cofactor for autoimmune diseases and cancer. Correlation … Continue reading →

Posted in News | Tagged , , | Comments Off on Different responses to EBV in MS and CFS could lead to diagnostic marker

Severity of infection leads to CFS in adolescents

Posted on 02/18/2014 by wames

Abstract This study focused on identifying risk factors for adolescent post-infectious chronic fatigue syndrome (CFS), utilizing a prospective, nested case–control longitudinal design in which over 300 teenagers with infectious mononucleosis (IM) [aka EBV or glandular fever] were identified through primary … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Severity of infection leads to CFS in adolescents

Epstein Barr virus following immune deficiency found in CFS subgroup

Posted on 01/22/2014 by wames

Abstract Epstein-Barr virus (EBV) has long been discussed as a possible cause or trigger of Chronic Fatigue Syndrome (CFS). In a subset of patients the disease starts with infectious mononucleosis and both enhanced and diminished EBV-specific antibody titers have been … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Epstein Barr virus following immune deficiency found in CFS subgroup

Valganciclovir is potential treatment for CFS subset

Posted on 09/02/2013 by wames

Research abstract  There is no known treatment for chronic fatigue syndrome (CFS). Little is known about its pathogenesis. Human herpesvirus 6 (HHV-6) and Epstein–Barr virus (EBV) have been proposed as infectious triggers. Method: Thirty CFS patients with elevated IgG antibody … Continue reading →

Posted in News | Tagged , , , | Comments Off on Valganciclovir is potential treatment for CFS subset

Deficient EBV cell response in CFS

Posted on 02/18/2013 by wames

Abstract Epstein-Barr virus (EBV) has long been discussed as a possible causeor trigger of Chronic Fatigue Syndrome (CFS). In a subset of patients the disease starts with infectious mononucleosis and both enhanced and diminished EBV-specific antibody titers have been reported. … Continue reading →

Posted in News | Tagged , , , , | Comments Off on Deficient EBV cell response in CFS

Antiviral valganciclovir helps CFS subgroup

Posted on 10/18/2012 by wames

In a study by Dr Jose Montoya in the USA half of CFS patients suffering from HHV-6 and EBV viruses make an improvement of 30% or more. Abstract Valganciclovir has been reported to improve physical and cognitive symptoms in patients … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Antiviral valganciclovir helps CFS subgroup